Atom | NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00

Funder: National Institutes of Health

Due Dates: June 16, 2025 (New/Renewal/Resubmission/Revision) | October 14, 2025 (New/Renewal/Resubmission/Revision) | February 17, 2026 (New/Renewal/Resubmission/Revision) | June 15, 2026 (New/Renewal/Resubmission/Revision) | October 14, 2026 (New/Renewal/Resubmission/Revision)

Funding Amounts: K99 phase: up to $100,000/year salary + $30,000/year research costs (up to 2 years); R00 phase: up to $249,000/year total costs (up to 3 years); max 5 years total.

Summary: Supports early-stage postdocs in cancer research to transition rapidly to independent, tenure-track positions by leading an independent clinical trial.

Key Information: Applicants must propose to lead an independent clinical trial; institutional nomination is required and each institution may submit only one application per scientific area per due date.

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)

Sign in to see full grant listing